Related Experiment Videos
[Stiff-Man syndrome with late onset].
P Vermersch1, J F Hurtevent, F Pasquier
1Service de Clinique Neurologique, Hôpital B, Lille.
Revue Neurologique
|January 1, 1992
Summary
Stiff-Man syndrome, a rare neurological disorder, can present with insomnia and rapid progression. Autoimmune factors, indicated by glutamic acid decarboxylase antibodies, may play a role.
Area of Science:
- Neurology
- Immunology
Background:
- Stiff-Man syndrome (SMS) is a rare neurological disorder characterized by muscle rigidity and spasms.
- Diagnostic criteria by Gordon, Januszko, and Kaufman were used for this case.
Observation:
- A 76-year-old patient presented with SMS, insomnia, and a rapid disease course.
- The patient died within two years of symptom onset.
Findings:
- Cerebrospinal fluid (CSF), electromyography (EMG), and immunological data suggest dysfunction in catecholaminergic and GABAergic systems.
- These dysfunctions may lead to a loss of inhibitory influences at segmental or suprasegmental levels.
- Antibodies against glutamic acid decarboxylase (GAD), a known marker for SMS, were detected.
Implications:
- The findings suggest a potential autoimmune pathogenesis for Stiff-Man syndrome.
- Understanding these neurochemical and immunological abnormalities is crucial for diagnosing and potentially treating SMS.
- This case highlights the importance of considering autoimmune markers in neurological disorders with rigidity and spasms.